The development of stimuli-responsive capsules has evolved into a major interdisciplinary research field with a variety of applications, [1] including cell encapsulation, [2] advanced drug delivery, [3] biomedical diagnostics, [4] micro-reactions, [5] and the formation of biomimetic protocells. [6] Numerous stimuli-responsive mechanisms have been integrated into "smart"
capsules to selectively release cargo by utilizing biological and externally applied triggers. [7] Synthetic capsules responsive to biological triggers (e.g., pH, redox reactions, and enzymes) are of particular interest because of their functional similarity to biological, dynamic systems (e.g., organelles, cells, and organs). [8] However, most stimuli-responsive capsules are engineered for a single biological trigger, and therefore lack the capacity to respond to complex microenvironments in the same, versatile way observed in nature. [9] It is therefore desirable to design dual-or multi-responsive capsules capable of interacting with complex biological environments. [10] Recently, we reported the rapid assembly of metal-phenolic networks (MPNs) based on metal coordination between phenolic materials, as a rapid and simple technology for depositing thin films and preparing responsive capsules.
[11] Natural phenolic building blocks are promising for biological applications, as many are generally recognized as safe (GRAS) by the U.S. Food and Drug Administration (FDA) [2, 11, 12] Although the multivalent coordination property of these materials allows capsules to disassemble in specific acidic conditions (e.g., < pH 4.0 for Fe III -TA capsules), these films have not yet been engineered to respond to multiple biological stimuli.
Herein, we engineer biologically relevant, dual-responsive boronate-phenolic network (BPN) capsules that combine the pH responsiveness of MPNs with the cis-diol responsiveness of boronate complexes. This dual-responsiveness is primarily achieved by exchanging the previously used multivalent coordination chemistry with dynamic boronate covalent chemistry. The complexation of boronic acid and cis-diols forms a reversible boronate ester, with its stability dependent on the environmental pH and concentration of competing cis-diols. [13] These features of boronic acid have been used for the fabrication of sensors, [14] responsive surfaces, [15] self-healing materials, [16] and drug delivery systems.
[17] Several groups have reported layer-by-layer (LbL)
capsules prepared by the multistep assembly of boronate-functionalized polymers with polyelectrolytes such as poly(sodium 4-styrene sulfonate) (PSS), [18] mannan, [19] poly(vinylalcohol) (PVA), [20] and chitosan. [21] However, most boronate-functionalized capsules are only stable and responsive to cis-diols under alkaline pH conditions (e.g., pH 9-11), which limits their potential in biological applications. Our design takes advantage of the efficient complexation between phenylboronic acid (benzene-1,4-diboronic acid, BDBA) and a phenolic building block (tannic acid, TA, Figure S1 ), to rapidly assemble boronate ester thin films on particulate templates. The films are responsive to acidic pH and in the presence of exogenous competing cis-diols at physiological pH (Figure 1a) . The templates can be removed after film formation, resulting in BPN capsules. Phenolic materials are excellent building blocks for the formation of boronate ester complexes, owing to the favorable syn-peri-planar arrangement of the aromatic hydroxyl groups combined with their electron-donating properties. [22] At alkaline pH, the building blocks of BDBA and TA rapidly assemble into a stable boronate ester network (Figure 1b , blue path). However, at acidic pH, and/or in the presence of exogenous competing cis-diols, the ester network rapidly dissociates, leading to capsule disassembly and cargo release (Figure 1b ,c, orange paths). BPN capsules are stable in the presence of the competing carbohydrates in biological environments, which gives BPN capsules the potential to be exploited in biological applications. For example, intracellular drug delivery systems, [23] extracellular remote-controlled drug delivery systems, [24] closed-loop insulin delivery systems, [25] biological targeting systems, [26] and biomimetic protocells, [6] could all potentially be engineered from BPN capsules. BPN capsules were fabricated by mixing BDBA and TA solutions in the presence of poly(sodium styrene sulfonate) (PSS)-stabilized calcium carbonate (CaCO 3 ) particulate templates at pH 8.5. PSS was used for template synthesis to form monodisperse CaCO 3 particles with a high loading capacity for cargos. [27] The covalent binding of BDBA and TA in the capsules was assessed using Fourier transform infrared (FTIR) spectrometry ( Figure S6) . Compared with the spectrum of TA, a new absorption peak appeared at 1370 cm -1 in the spectrum of the capsules due to the B-O stretching vibration. [20] The peak at 1625 cm -1
, corresponding to the O-H bending vibration of hydroxyl groups in TA, decreased. [28] The formation of BPN films on CaCO 3
particles shifted the particle zeta potential from -5 ± 5 to -40 ± 2 mV, which is more than a two-fold shift compared to our previously reported Fe III -TA coating (-18 ± 4 mV).
[11a] The negative zeta potential was likely due to the phenolic building blocks and charged BDBA, which should be able to further bind with competing cis-diols.
[17b] Finally, the featureless X-ray diffraction (XRD) data indicated that the films were amorphous (Figure S7 ), similar to MPNs, [11b] but different to the crystalline structure of covalent organic frameworks (COFs). [29] Monodisperse, spherical capsules were readily observed under differential interference contrast (DIC) microscopy (Figure 2a) . Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that dried capsules had features similar to polymeric capsules, such as folds and creases, due to collapse during the air drying process (Figure 2b,c) . [18] High-angle annular dark field (HAADF) imaging and atomic force microscopy (AFM) imaging showed the smooth surface of the capsules, suggesting that no excess complexation was occurring (Figure 2d,e) . Energy-dispersive X-ray spectroscopy (EDX) mapping revealed the elemental compositions of BPN capsules. The BPN film thickness (10.5 ± 1.2 nm) is similar to that reported for MPN capsules (Figure 2f) . As shown in Figure 2g ,h, the formation of BPN films can also be performed on silver nanoparticles, implying an important extension of this technique towards coating nanoparticles, where the core can either be retained as a functional component, or removed to form nanoscale hollow capsules. which take approximately 10 days at pH 4.0 to reach 10%. [11a] Mannitol could also cleave the crosslinks of the BPN, as evidenced by the decrease in the capsule population. These results correspond well with the NMR studies of BPN complexation and cis-diol competitive interactions.
Previously reported boronate-functionalized capsules obtained through LbL assembly only degraded under alkaline pH conditions (e.g., pH 9-11), because only the tetravalent charged borate moiety, which exists at high pH, could bind with cis-diols to form a stable complex.
[17b]
However, our phenolic building blocks can form a stable ester network with BDBA and dissociate in the presence of competing excess cis-diols at physiological pH. Based on the zeta-potential and NMR studies, this could be because the complexation of BDBA and TA induces the formation of thermodynamically stable, charged BDBA in the capsules, which is favorable for binding with excess cis-diols.
To demonstrate encapsulation and release from the BPN capsules, doxorubicin hydrochloride (DOX) was chosen as a model cargo and loaded into CaCO 3 particles. [27] As shown in Figure 3b and Figure S8 , the release of DOX was negligible at pH 7.4, however when the pH was decreased to 5.0 the DOX release was dramatically accelerated. This demonstrates the potential of these capsules for achieving intracellular endocytic pH-triggered cargo release. It is well known that carbohydrates are actively involved in a wide range of biological processes, such as intercellular recognition. [30] These carbohydrates might be an unexpected trigger for BPN capsule destabilization in vivo, which would greatly limit their biological applications.
[17c] Therefore, we studied the stability of BPN capsules in competing carbohydrates to simulate conditions expected in vivo. As shown in Figure 4a ,b, the capsules remained spherical and intact in human blood plasma (HBP) even for 12 h. In contrast, when the HBP was doped with 100 mM mannitol, the number of capsules decreased. This indicated that the BPN capsules are stable, even in the presence of the competing carbohydrates present in blood, and are still capable of disassembling in the presence of excess mannitol. Positron emission tomography (PET) was used as a preliminary means to evaluate the in vivo stability of these capsules in a tumor mice model to determine if the carbohydrate metabolism of tumors would make the capsules unstable in vivo (Figure 4c) . 64 Cu was incorporated into the BPN capsules at pH 8.0 through free hydroxyl groups, [11b] resulting in PET-active 64 Cu/BPN capsules. After tumor formation, 64 Cu/BPN capsules were injected locally and the stability was evaluated by PET/computed tomography (CT) imaging.
Figure 4d,e showed that even after 12 h the PET signal from the capsules was still mainly located at the tumor site. This suggested that these capsules exhibit good stability in vivo, which will be fundamental for exploring future biological applications.
[17c] In summary, we report a pH and cis-diols dual-responsive capsule system through the complexation of phenylboronic acid (BDBA) and a polyphenol (TA) to form robust films on particulate templates. The BPN capsules have a chemically defined mechanism for the pH and cis-diols responsiveness due to the dynamic nature of the reversible boronate ester. The release of DOX from the capsules could be increased by decreasing pH and/or adding cis-diols. Stability experiments suggested that the capsules were stable at physiological pH and in vivo, even in the presence of competing carbohydrates. This efficient combination of rapid complexation and dual stimuli-responsive mechanisms provides a novel avenue for the design of "smart" capsules for a range of biological applications, including closed-loop insulin delivery systems by glucose-activation, anticancer drug delivery by acidic pH-trigger, biological targeting by selective interaction with furanoside carbohydrates, or biomimic modeling as microreactors responsive to multiple environmental changes.
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